Cargando…
Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review
PURPOSE: Cancer patients with COVID-19 likely express biomarker changes in circulation. However, the biomarkers used in SARS-CoV-2 infected cancer patients for COVID-19 severity and prognosis are largely unclear. Therefore, this systematic review aims to determine what biomarkers were measured in ca...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057983/ https://www.ncbi.nlm.nih.gov/pubmed/35523009 http://dx.doi.org/10.1016/j.tranon.2022.101443 |